BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $261,000 | -9.7% | 3,361 | 0.0% | 0.05% | +6.5% |
| Q4 2021 | $289,000 | +7.0% | 3,361 | 0.0% | 0.05% | 0.0% |
| Q3 2021 | $270,000 | -0.4% | 3,361 | 0.0% | 0.05% | -63.5% |
| Q2 2021 | $271,000 | -4.2% | 3,361 | 0.0% | 0.13% | -14.3% |
| Q1 2021 | $283,000 | +4.8% | 3,361 | 0.0% | 0.15% | -0.7% |
| Q4 2020 | $270,000 | 0.0% | 3,361 | 0.0% | 0.15% | +0.7% |
| Q3 2020 | $270,000 | -6.6% | 3,361 | 0.0% | 0.15% | +17.6% |
| Q2 2020 | $289,000 | +2.8% | 3,361 | 0.0% | 0.12% | -15.0% |
| Q4 2019 | $281,000 | -4.4% | 3,361 | 0.0% | 0.15% | -10.4% |
| Q3 2019 | $294,000 | +6.9% | 3,361 | 0.0% | 0.16% | +5.1% |
| Q2 2019 | $275,000 | +0.7% | 3,361 | 0.0% | 0.16% | -5.5% |
| Q1 2019 | $273,000 | +16.7% | 3,361 | -5.6% | 0.16% | +46.0% |
| Q4 2018 | $234,000 | -14.9% | 3,561 | -0.1% | 0.11% | -51.9% |
| Q3 2018 | $275,000 | +4.6% | 3,565 | +0.0% | 0.24% | +0.4% |
| Q2 2018 | $263,000 | +13.4% | 3,564 | -0.0% | 0.23% | +129.4% |
| Q1 2018 | $232,000 | -21.4% | 3,565 | -21.9% | 0.10% | -12.1% |
| Q4 2017 | $295,000 | +3.1% | 4,565 | 0.0% | 0.12% | +5.5% |
| Q3 2017 | $286,000 | +20.7% | 4,565 | +0.1% | 0.11% | +3.8% |
| Q1 2017 | $237,000 | -20.7% | 4,561 | -27.3% | 0.11% | -34.6% |
| Q3 2016 | $299,000 | +8.7% | 6,275 | +3.3% | 0.16% | +7.3% |
| Q2 2016 | $275,000 | +10.0% | 6,075 | 0.0% | 0.15% | -1.3% |
| Q1 2016 | $250,000 | +7.8% | 6,075 | 0.0% | 0.15% | +5.5% |
| Q4 2015 | $232,000 | -42.0% | 6,075 | +6.1% | 0.14% | -42.5% |
| Q2 2015 | $400,000 | -99.9% | 5,725 | 0.0% | 0.25% | -1.2% |
| Q1 2015 | $392,163,000 | +31.8% | 5,725 | +41.0% | 0.26% | +22.6% |
| Q4 2014 | $297,631,000 | -30.0% | 4,061 | -31.5% | 0.21% | -29.7% |
| Q3 2014 | $425,237,000 | -0.7% | 5,925 | 0.0% | 0.30% | +0.3% |
| Q2 2014 | $428,378,000 | -1.7% | 5,925 | 0.0% | 0.30% | -8.4% |
| Q1 2014 | $435,962,000 | +12.5% | 5,925 | +0.4% | 0.32% | +6.3% |
| Q3 2013 | $387,571,000 | -5.2% | 5,900 | 0.0% | 0.30% | -7.6% |
| Q2 2013 | $408,693,000 | – | 5,900 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |